RU2012107457A - Ингибиторы ухудшения когнитивных способностей - Google Patents
Ингибиторы ухудшения когнитивных способностей Download PDFInfo
- Publication number
- RU2012107457A RU2012107457A RU2012107457/04A RU2012107457A RU2012107457A RU 2012107457 A RU2012107457 A RU 2012107457A RU 2012107457/04 A RU2012107457/04 A RU 2012107457/04A RU 2012107457 A RU2012107457 A RU 2012107457A RU 2012107457 A RU2012107457 A RU 2012107457A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- haloalkyl
- alkyl
- Prior art date
Links
- 208000028698 Cognitive impairment Diseases 0.000 title claims 5
- 208000010877 cognitive disease Diseases 0.000 title claims 5
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 35
- 150000003839 salts Chemical class 0.000 claims abstract 24
- 125000000217 alkyl group Chemical group 0.000 claims abstract 22
- 125000003118 aryl group Chemical group 0.000 claims abstract 10
- 229910052736 halogen Inorganic materials 0.000 claims abstract 9
- 150000002367 halogens Chemical class 0.000 claims abstract 9
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims abstract 8
- 125000001424 substituent group Chemical group 0.000 claims abstract 8
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract 5
- 125000003277 amino group Chemical group 0.000 claims abstract 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims abstract 4
- 229910052794 bromium Inorganic materials 0.000 claims abstract 2
- 229910052801 chlorine Inorganic materials 0.000 claims abstract 2
- 229910052731 fluorine Inorganic materials 0.000 claims abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract 2
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 13
- 238000000034 method Methods 0.000 claims 13
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 8
- 238000001228 spectrum Methods 0.000 claims 8
- 239000010681 turmeric oil Substances 0.000 claims 8
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims 5
- 239000003638 chemical reducing agent Substances 0.000 claims 4
- 239000012043 crude product Substances 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 claims 4
- 230000005764 inhibitory process Effects 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 3
- 238000005576 amination reaction Methods 0.000 claims 2
- 230000003941 amyloidogenesis Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- JYODOEJCLYYBRE-TVRKMHQQSA-N (6r)-2-methyl-6-(4-methylcyclohexa-1,5-dien-1-yl)-n-(2-methylpropyl)hept-2-en-4-amine Chemical compound CC(C)CNC(C=C(C)C)C[C@@H](C)C1=CCC(C)C=C1 JYODOEJCLYYBRE-TVRKMHQQSA-N 0.000 claims 1
- MDTGNJMONJEHRU-JVWICGRDSA-N (6r)-2-methyl-6-(4-methylcyclohexa-1,5-dien-1-yl)hept-2-en-4-ol Chemical compound CC(C)=CC(O)C[C@@H](C)C1=CCC(C)C=C1 MDTGNJMONJEHRU-JVWICGRDSA-N 0.000 claims 1
- UOGAUFFBPTVCCY-DUSLRRAJSA-N (6r)-2-methyl-6-(4-methylphenyl)-n-(2-methylpropyl)hept-2-en-4-amine Chemical compound CC(C)CNC(C=C(C)C)C[C@@H](C)C1=CC=C(C)C=C1 UOGAUFFBPTVCCY-DUSLRRAJSA-N 0.000 claims 1
- JYODOEJCLYYBRE-HFCFLWKCSA-N (6s)-2-methyl-6-(4-methylcyclohexa-1,5-dien-1-yl)-n-(2-methylpropyl)hept-2-en-4-amine Chemical compound CC(C)CNC(C=C(C)C)C[C@H](C)C1=CCC(C)C=C1 JYODOEJCLYYBRE-HFCFLWKCSA-N 0.000 claims 1
- MDTGNJMONJEHRU-OWYJLGKBSA-N (6s)-2-methyl-6-(4-methylcyclohexa-1,5-dien-1-yl)hept-2-en-4-ol Chemical compound CC(C)=CC(O)C[C@H](C)C1=CCC(C)C=C1 MDTGNJMONJEHRU-OWYJLGKBSA-N 0.000 claims 1
- UOGAUFFBPTVCCY-KKFHFHRHSA-N (6s)-2-methyl-6-(4-methylphenyl)-n-(2-methylpropyl)hept-2-en-4-amine Chemical compound CC(C)CNC(C=C(C)C)C[C@H](C)C1=CC=C(C)C=C1 UOGAUFFBPTVCCY-KKFHFHRHSA-N 0.000 claims 1
- NRBFEAZFHRHFFQ-CFMCSPIPSA-N (6s)-2-methyl-6-(4-methylphenyl)hept-2-en-4-ol Chemical compound CC(C)=CC(O)C[C@H](C)C1=CC=C(C)C=C1 NRBFEAZFHRHFFQ-CFMCSPIPSA-N 0.000 claims 1
- JYODOEJCLYYBRE-UHFFFAOYSA-N 2-methyl-6-(4-methylcyclohexa-1,5-dien-1-yl)-n-(2-methylpropyl)hept-2-en-4-amine Chemical compound CC(C)CNC(C=C(C)C)CC(C)C1=CCC(C)C=C1 JYODOEJCLYYBRE-UHFFFAOYSA-N 0.000 claims 1
- MDTGNJMONJEHRU-UHFFFAOYSA-N 2-methyl-6-(4-methylcyclohexa-1,5-dien-1-yl)hept-2-en-4-ol Chemical compound CC(C)=CC(O)CC(C)C1=CCC(C)C=C1 MDTGNJMONJEHRU-UHFFFAOYSA-N 0.000 claims 1
- UOGAUFFBPTVCCY-UHFFFAOYSA-N 2-methyl-6-(4-methylphenyl)-n-(2-methylpropyl)hept-2-en-4-amine Chemical compound CC(C)CNC(C=C(C)C)CC(C)C1=CC=C(C)C=C1 UOGAUFFBPTVCCY-UHFFFAOYSA-N 0.000 claims 1
- 208000000044 Amnesia Diseases 0.000 claims 1
- 208000026139 Memory disease Diseases 0.000 claims 1
- 206010034719 Personality change Diseases 0.000 claims 1
- 230000006933 amyloid-beta aggregation Effects 0.000 claims 1
- 206010002022 amyloidosis Diseases 0.000 claims 1
- NRBFEAZFHRHFFQ-UHFFFAOYSA-N bisacumol Chemical compound CC(C)=CC(O)CC(C)C1=CC=C(C)C=C1 NRBFEAZFHRHFFQ-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000027928 long-term synaptic potentiation Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000006984 memory degeneration Effects 0.000 claims 1
- 208000023060 memory loss Diseases 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 210000002569 neuron Anatomy 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 8
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/25—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/05—Alcohols containing rings other than six-membered aromatic rings
- C07C33/14—Alcohols containing rings other than six-membered aromatic rings containing six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/28—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings
- C07C33/30—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings monocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
- C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/18—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23032609P | 2009-07-31 | 2009-07-31 | |
| US61/230,326 | 2009-07-31 | ||
| US30868610P | 2010-02-26 | 2010-02-26 | |
| US61/308,686 | 2010-02-26 | ||
| PCT/US2010/044136 WO2011014880A1 (en) | 2009-07-31 | 2010-08-02 | Inhibitors of cognitive decline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2012107457A true RU2012107457A (ru) | 2013-09-10 |
Family
ID=43529740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012107457/04A RU2012107457A (ru) | 2009-07-31 | 2010-08-02 | Ингибиторы ухудшения когнитивных способностей |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9192585B2 (https=) |
| EP (1) | EP2458983B1 (https=) |
| JP (1) | JP2013501006A (https=) |
| CN (1) | CN102595884B (https=) |
| AU (2) | AU2010278711A1 (https=) |
| BR (1) | BR112012002246A2 (https=) |
| DK (1) | DK2458983T3 (https=) |
| ES (1) | ES2547730T3 (https=) |
| IL (1) | IL217833A0 (https=) |
| RU (1) | RU2012107457A (https=) |
| SG (2) | SG10201506978UA (https=) |
| WO (1) | WO2011014880A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201404913QA (en) | 2009-04-09 | 2014-11-27 | Cognition Therapeutics Inc | Inhibitors of cognitive decline |
| RU2012107457A (ru) * | 2009-07-31 | 2013-09-10 | Когнишн Терапьютикс, Инк. | Ингибиторы ухудшения когнитивных способностей |
| US20130071330A1 (en) * | 2010-02-26 | 2013-03-21 | Susan Catalano | Methods of identifying agents effective to treat cognitive decline and diseases associated therewith |
| US9499462B2 (en) | 2011-02-02 | 2016-11-22 | Cognition Therapeutics, Inc. | Isolated compounds from turmeric oil and methods of use |
| EP2690969B1 (en) * | 2011-03-29 | 2018-10-03 | Council of Scientific & Industrial Research | Process for the modification of curcuma aromatica essential oil |
| GB201111319D0 (en) * | 2011-07-04 | 2011-08-17 | Univ Leuven Kath | Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa |
| RU2014111079A (ru) * | 2011-08-25 | 2015-09-27 | Когнишн Терапьютикс, Инк. | Композиции и способы для лечения нейродегенеративного заболевания |
| CA2846611A1 (en) * | 2011-08-25 | 2013-02-28 | Cognition Therapeutics, Inc. | Compositions and methods for treating neurodegenerative disease |
| DK3099296T3 (en) | 2014-01-31 | 2019-04-15 | Cognition Therapeutics Inc | ISO-INDOLINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE |
| EP3634394B1 (en) | 2017-05-15 | 2025-12-24 | Cognition Therapeutics, Inc. | Compositions for treating neurodegenerative diseases |
| WO2026030341A1 (en) | 2024-07-29 | 2026-02-05 | Cognition Therapeutics, Inc. | Zervimesine for treating neurodegenerative disease |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA732136B (en) | 1972-04-12 | 1974-03-27 | Lilly Co Eli | Dopamine derivatives |
| US4321386A (en) | 1981-01-28 | 1982-03-23 | Mead Johnson & Company | Quaternary piperidinium halides |
| DK171627B1 (da) | 1983-01-31 | 1997-03-03 | Lilly Co Eli | Anvendelse af beta-phenethanolamin og farmaceutiskacceptable salte deraf samt dyrefoderpræblanding med indhold deraf |
| JPS62283922A (ja) | 1986-05-30 | 1987-12-09 | Tsumura Juntendo Inc | 血小板凝集抑制剤 |
| US4697024A (en) | 1986-11-24 | 1987-09-29 | Merrell Dow Pharmaceuticals Inc. | Medroxalol intermediates |
| US4958029A (en) | 1987-01-13 | 1990-09-18 | Banyu Pharmaceutical Co., Ltd. | Process for the production of isoindoline derivatives, novel intermediates and process for their production |
| JPH01180822A (ja) | 1988-01-12 | 1989-07-18 | Dainippon Pharmaceut Co Ltd | 抗遅延型アレルギー剤 |
| EP0507863A4 (en) | 1989-12-28 | 1993-07-07 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
| DE4000610A1 (de) | 1990-01-11 | 1991-07-18 | Knoll Ag | Verfahren zur herstellung von optisch aktiven 3-amino-1-arylbutanen und 3-benzylamino-1-arylbutanen |
| JP2818958B2 (ja) | 1990-02-23 | 1998-10-30 | 塩野義製薬株式会社 | ４―（４―アルコキシフェニル）―２―ブチルアミン誘導体およびその製造法 |
| JPH045266A (ja) | 1990-04-24 | 1992-01-09 | Toyo Pharma- Kk | ドパミン誘導体の製造方法 |
| DE4142366A1 (de) * | 1991-07-15 | 1993-06-24 | Thomae Gmbh Dr K | Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE4123341A1 (de) * | 1991-07-15 | 1993-01-21 | Thomae Gmbh Dr K | Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| US6011068A (en) | 1991-08-23 | 2000-01-04 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| CN1192011C (zh) | 1991-08-23 | 2005-03-09 | Nps药物有限公司 | 对钙受体具活性的芳烷基胺化合物 |
| US6610493B1 (en) | 1993-06-17 | 2003-08-26 | Brigham And Women's Hospital | Screening compounds for the ability to alter the production of amyloid-β peptide |
| CA2115900A1 (en) | 1993-02-22 | 1994-08-23 | Gerald W. Becker | Pharmaceutical screens and antibodies |
| US6211244B1 (en) | 1994-10-21 | 2001-04-03 | Nps Pharmaceuticals, Inc. | Calcium receptor-active compounds |
| JP3522930B2 (ja) * | 1995-12-06 | 2004-04-26 | 花王株式会社 | 抗菌剤及びこれを含有する口腔用組成物 |
| WO1997030038A1 (en) | 1996-02-15 | 1997-08-21 | Mitsubishi Chemical Corporation | Diarylsultam derivatives |
| US6235731B1 (en) | 1996-04-24 | 2001-05-22 | Takeda Chemical Industries, Ltd. | Fused imidazopyridine derivatives as antihyperlipidemic agents |
| US6518315B1 (en) | 1997-10-21 | 2003-02-11 | The University Of Sydney | Medicinal uses of phenylaikanols and derivatives |
| IL138686A0 (en) | 1999-10-01 | 2001-10-31 | Pfizer Prod Inc | α- SULFONYLAMINO HYDROXAMIC ACID INHIBITORS OF MATRIX METALLOPROTEINASES FOR THE TREATMENT OF PERIPHERAL OR CENTRAL NERVOUS SYSTEM DISORDERS |
| AU2300001A (en) | 1999-10-22 | 2001-05-08 | Board Of Trustees Of The University Of Illinois, The | Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease |
| DE10027151A1 (de) | 2000-05-31 | 2001-12-06 | Bayer Ag | Herbizide Mittel auf Basis von substituierten Carbonsäureamiden |
| JP4312402B2 (ja) | 2001-07-31 | 2009-08-12 | 有限会社大長企画 | 抗うつ剤、抗更年期障害剤、抗老人性痴呆症剤、抗アルツハイマー剤 |
| US20030073681A1 (en) | 2001-08-21 | 2003-04-17 | Hauske James R. | 2-substituted piperidines that are ligands for monoamine receptors and transporters |
| US6991814B2 (en) * | 2001-12-13 | 2006-01-31 | Council Of Scientific And Industrial Research | Herbal medicaments for the treatment of neurocerebrovascular disorders |
| UA82057C2 (en) * | 2001-12-14 | 2008-03-11 | Каунсил Оф Сайентифик Энд Индастриал Рисёрч | COMPOSITION basED on AR-D-turmeron and α- anD β-turmeron FOR TREATING NEUROCEREBROVASCULAR DISORDERS |
| JP2004002517A (ja) | 2002-05-31 | 2004-01-08 | Dae Sil Kim | 生姜成分を含む石鹸の組成物及びその製造方法 |
| DE10320560A1 (de) | 2003-05-07 | 2004-01-29 | Brosig, Stefan, Dr. | Mittel zur Bekämpfung der Alzheimer Erkrankung und/oder der Parkinson Krankheit |
| US20050032827A1 (en) | 2003-06-12 | 2005-02-10 | Donna Oksenberg | Sigma ligands for neuronal regeneration and functional recovery |
| HRP20060326A2 (hr) | 2004-03-12 | 2007-02-28 | Egis Gy�gyszergy�r Nyrt. | Kombinirani farmaceutski kompozit za inhibiciju pada kognitivnih funkcija |
| EP1752144A4 (en) * | 2004-05-31 | 2007-07-11 | Kaneka Corp | AGENT FOR PREVENTING / IMPROVING LIFESTYLE DISEASES CONTAINING AN ESSENTIAL CURCUMA OIL COMPONENT |
| DK1794313T3 (da) | 2004-06-21 | 2013-07-22 | Proteome Sciences Plc | Fremgangsmåde til screeninger der anvender C-ABL, FYN og SYK i kombination med tau-protein |
| TW200613272A (en) | 2004-08-13 | 2006-05-01 | Astrazeneca Ab | Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| EP1797036A1 (en) | 2004-09-10 | 2007-06-20 | UCB Pharma, S.A. | Sigma receptor ligands |
| WO2006066118A2 (en) | 2004-12-15 | 2006-06-22 | Neuralab Limited | Contextual fear test for predicting efficacy of alzheimer immunotherapeutic treatment |
| WO2006094724A2 (en) | 2005-03-05 | 2006-09-14 | Abbott Gmbh & Co. Kg | Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| KR20080041624A (ko) | 2005-06-15 | 2008-05-13 | 대릭 에스. 에치. 엘. 김 | 베타-아밀로이드 단백질-유발 안질환의 치료 방법 |
| EP1745778A3 (en) | 2005-07-20 | 2007-03-07 | Speedel Experimenta AG | Diaminoalcohols as therapeutic compounds |
| ITRM20060007A1 (it) | 2006-01-05 | 2007-07-06 | Univ Bari | Recettore sigma-2 metodo di screening di ligandi specifici e uso degli stessi in metodi diagnostici o terapeutici |
| CA2644093A1 (en) * | 2006-03-17 | 2007-09-27 | Herbalscience Singapore Pte. Ltd. | Extracts and methods comprising curcuma species |
| US20100029654A1 (en) | 2006-03-23 | 2010-02-04 | Mount Sinai School Of Medicine | Cardiovascular compositions and use of the same for the treatment of alzheimer's disease |
| US7561775B2 (en) | 2006-08-22 | 2009-07-14 | Senko Advanced Components, Inc. | Fiber optic protective shutter |
| WO2008042755A2 (en) | 2006-09-29 | 2008-04-10 | Cognition Therapeutics, Inc. | Inhibitors of cognitive decline |
| US20100028333A1 (en) | 2006-12-15 | 2010-02-04 | Getty Krista L | Receptor for amyloid beta and uses thereof |
| KR20100029079A (ko) | 2007-05-15 | 2010-03-15 | 헬리콘 테라퓨틱스 인코퍼레이티드 | Ｇｐｒ12의 저해로 인지 질환을 치료하는 방법 |
| CN101121670A (zh) | 2007-09-11 | 2008-02-13 | 上海紫源制药有限公司 | 一种3,4-二甲氧基-N-[3-(4-甲氧基苯基)-1-甲基-正丙基]-β-苯乙胺盐酸盐的制备方法 |
| RU2461551C2 (ru) | 2007-10-24 | 2012-09-20 | Астеллас Фарма Инк. | Азолкарбоксамидное соединение или его фармацевтически приемлемая соль |
| US8168800B2 (en) | 2007-11-02 | 2012-05-01 | The Regents Of The University Of California | Aβ-binding small molecules |
| EP2138104A1 (en) | 2008-06-25 | 2009-12-30 | Vibra Tech AB | Core biopsy arrangement |
| WO2010062260A1 (en) | 2008-11-29 | 2010-06-03 | The Thailand Research Fund | Virus and target cell interaction inhibition |
| WO2010088450A2 (en) | 2009-01-30 | 2010-08-05 | Celladon Corporation | Methods for treating diseases associated with the modulation of serca |
| EP2408905B1 (en) | 2009-03-16 | 2017-05-10 | Pangu Biopharma Limited | Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| SG10201404913QA (en) | 2009-04-09 | 2014-11-27 | Cognition Therapeutics Inc | Inhibitors of cognitive decline |
| RU2012107457A (ru) * | 2009-07-31 | 2013-09-10 | Когнишн Терапьютикс, Инк. | Ингибиторы ухудшения когнитивных способностей |
| US20130071330A1 (en) | 2010-02-26 | 2013-03-21 | Susan Catalano | Methods of identifying agents effective to treat cognitive decline and diseases associated therewith |
| RU2014111079A (ru) | 2011-08-25 | 2015-09-27 | Когнишн Терапьютикс, Инк. | Композиции и способы для лечения нейродегенеративного заболевания |
-
2010
- 2010-08-02 RU RU2012107457/04A patent/RU2012107457A/ru not_active Application Discontinuation
- 2010-08-02 AU AU2010278711A patent/AU2010278711A1/en not_active Abandoned
- 2010-08-02 EP EP10805177.2A patent/EP2458983B1/en active Active
- 2010-08-02 CN CN201080043697.0A patent/CN102595884B/zh not_active Expired - Fee Related
- 2010-08-02 SG SG10201506978UA patent/SG10201506978UA/en unknown
- 2010-08-02 US US13/388,128 patent/US9192585B2/en active Active
- 2010-08-02 JP JP2012523127A patent/JP2013501006A/ja active Pending
- 2010-08-02 BR BR112012002246A patent/BR112012002246A2/pt not_active IP Right Cessation
- 2010-08-02 SG SG2012006805A patent/SG178191A1/en unknown
- 2010-08-02 DK DK10805177.2T patent/DK2458983T3/en active
- 2010-08-02 ES ES10805177.2T patent/ES2547730T3/es active Active
- 2010-08-02 WO PCT/US2010/044136 patent/WO2011014880A1/en not_active Ceased
-
2012
- 2012-01-30 IL IL217833A patent/IL217833A0/en unknown
-
2015
- 2015-10-12 AU AU2015242947A patent/AU2015242947B2/en not_active Ceased
- 2015-10-16 US US14/885,768 patent/US9815770B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20120129945A1 (en) | 2012-05-24 |
| EP2458983A4 (en) | 2012-12-19 |
| EP2458983B1 (en) | 2015-07-08 |
| IL217833A0 (en) | 2012-03-29 |
| AU2015242947A1 (en) | 2015-10-29 |
| HK1171624A1 (en) | 2013-04-05 |
| AU2010278711A1 (en) | 2012-02-23 |
| US9815770B2 (en) | 2017-11-14 |
| SG178191A1 (en) | 2012-03-29 |
| WO2011014880A1 (en) | 2011-02-03 |
| BR112012002246A2 (pt) | 2019-09-24 |
| CN102595884A (zh) | 2012-07-18 |
| US20160137588A1 (en) | 2016-05-19 |
| EP2458983A1 (en) | 2012-06-06 |
| ES2547730T3 (es) | 2015-10-08 |
| CN102595884B (zh) | 2014-12-03 |
| DK2458983T3 (en) | 2015-10-05 |
| SG10201506978UA (en) | 2015-10-29 |
| AU2015242947B2 (en) | 2017-09-28 |
| JP2013501006A (ja) | 2013-01-10 |
| US9192585B2 (en) | 2015-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012107457A (ru) | Ингибиторы ухудшения когнитивных способностей | |
| RU2011145321A (ru) | Ингибиторы снижения когнитивных способностей | |
| JP2013501006A5 (https=) | ||
| RU2014113548A (ru) | Нейроактивные стероиды, композиции и их применения | |
| WO2008108380A3 (en) | Pyrrole compounds | |
| EA200870321A1 (ru) | Способ получения 4-оксохинолинового соединения | |
| JP2012523418A5 (https=) | ||
| NO20064364L (no) | Derivater av alkylpiperazin- og alkylhomopiperazinkarboksylater, fremgangsmate for fremstilling derav og anvendelse av forbindelsene som FAAH enzyminhibitorer | |
| RU2015101532A (ru) | Замещенные бициклические алкокси-пиразольные аналоги в качестве аллостерических модуляторов рецепторов mglur5 | |
| UA80116C2 (en) | Amino acids with affinity for the alpha-2-delta-protein | |
| WO2012069402A1 (en) | Substituted cyclopentyl - azines as casr- active compounds | |
| RU2015101512A (ru) | Замещенные бициклические алкокси-пиразольные аналоги в качестве аллостерических модуляторов рецепторов mglur5 | |
| Graebin et al. | Synthesis and in vitro activity of limonene derivatives against Leishmania and Trypanosoma | |
| WO2003097025A3 (en) | A process for preparing pharmaceutical compositions containing 4-aminoquinolines compounds for treatment of inflammatory disorders of the eye and compositions resulting therefrom | |
| EA014959B3 (ru) | Ингибиторы глицинового переносчика-1 | |
| US8785494B2 (en) | Calcium sensing receptor modulating compounds and pharmaceutical use thereof | |
| JPH09505591A (ja) | 治療用置換グアニジン類 | |
| RU2007143509A (ru) | Производные ацетилена | |
| JP2011507988A5 (https=) | ||
| RU2014131017A (ru) | Хиназолиноновые производные в качестве ингибиторов hcv | |
| JP7039579B2 (ja) | 抗癌剤としての４－アニリノ－キノリン化合物 | |
| CA2552195A1 (en) | 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level | |
| MX2011005971A (es) | Nuevas formas polimorficas de un derivado de azabiciclo-trifluorom etil benzamida. | |
| WO2008003620A3 (de) | Elektrochemische herstellung sterisch gehinderter amine | |
| JP2017515814A (ja) | ニトロン化合物及びパーソナルケアにおけるその使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20150113 |